Regulation 76 Limitation on withdrawal from pharmaceutical lists while fitness investigations or proceedings are ongoing
If F1NHS England would otherwise remove an NHS chemist (C) from a pharmaceutical list under regulation 75, but—
is investigating C in order to see whether there are grounds for exercising its powers in relation to C under section 151, 152 or 154 of the 2006 Act M1(which relate to disqualification of practitioners, contingent removal and suspension), or regulation 80;
has decided to—
remove C from a pharmaceutical list under section 151 or 152 of the 2006 Act or regulation 80, or
contingently remove C under section 152 of the 2006 Act,
but C has not yet been removed or contingently removed; or
has suspended C under section 154 of the 2006 Act,
it must not, without the consent of the Secretary of State, remove C from that pharmaceutical list under regulation 75 until the relevant investigation or proceedings have been concluded.
If C's name is kept on a pharmaceutical list pursuant to paragraph (1)—
as regards C, NHS England may exercise its functions under—
Part 11 of these Regulations, and
Chapter 6 of Part 7 of the 2006 Act (pharmaceutical services and local pharmaceutical services – disqualification); but
for all other purposes, C is to be treated as having been removed from that pharmaceutical list under regulation 75.
Annotations
Textual amendments
- F1
Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1
Marginal citations
- M1
Section 154 has been amended by S.I. 2010/22.